Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

CD5CAR

Home DrugsCD5CAR

CD5CAR

Unknown Manufacturer

Generate AI report

Share to Twitter Share to Facebook Share to LinkedIn Share to Reddit

Patents

One entry per invention. Patent families filed in the US, EP, WO and CN offices.

Chimeric antigen receptor T cell of targeted CD5 molecule and anti-tumor application of chimeric antigen receptor T cell
Applicant: SHENZHEN PREGENE BIOPHARMACEUTICAL CO LTDPriority: 2023
CN
Antibody specifically binding to CD7 and application thereof in preparation of chimeric antigen receptor
Applicant: CAS BLOOD HEMATONOSIS HOSPITAL INST OF BLOOD HEMATONOSIS CASPriority: 2022
CN
Chimeric antigen receptor, lentivirus, modified T cell and application thereof
Applicant: SHENZHEN PREGENE BIOPHARMACEUTICAL CO LTDPriority: 2023
CN